Tenax Therapeutics, Inc. (TENX)

Tenax Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	94.85	9.79	2.12	5.58	6.25
Short-Term Investments	-	-	-	-	0.46
Cash & Short-Term Investments	94.85	9.79	2.12	5.58	6.71
Cash Growth	868.66%	361.09%	-61.97%	-16.82%	24.32%
Prepaid Expenses	1.77	1.64	0.74	0.11	0.08
Other Current Assets	0.06	0.25	0.35	-	-
Total Current Assets	96.69	11.68	3.21	5.69	6.8
Property, Plant & Equipment	-	-	0.19	0.29	0.06
Other Long-Term Assets	-	0	0.01	0.01	0.01
Total Assets	96.69	11.69	3.4	5.99	6.87
Accounts Payable	3.16	2.07	0.45	0.86	0.76
Accrued Expenses	1.54	1.01	0.66	0.6	1.18
Short-Term Debt	-	0.5	0.62	-	-
Current Portion of Long-Term Debt	-	-	-	-	0.12
Current Portion of Leases	-	-	0.12	0.11	0.06
Total Current Liabilities	4.69	3.59	1.85	1.56	2.12
Long-Term Debt	-	-	-	-	0.12
Long-Term Leases	-	-	0.06	0.18	-
Total Liabilities	4.69	3.59	1.91	1.75	2.24
Common Stock	-	-	0	0	0
Additional Paid-In Capital	406.85	305.35	291.03	282.74	250.64
Retained Earnings	-314.86	-297.25	-289.54	-278.49	-246.02
Comprehensive Income & Other	-	-	-	-	-0
Total Common Equity	91.99	8.1	1.49	4.24	4.63
Shareholders' Equity	91.99	8.1	1.49	4.24	4.63
Total Liabilities & Equity	96.69	11.69	3.4	5.99	6.87
Total Debt	-	0.5	0.81	0.29	0.31
Net Cash (Debt)	94.85	9.29	1.32	5.29	6.41
Net Cash Growth	920.89%	606.12%	-75.14%	-17.40%	22.56%
Net Cash Per Share	2.69	37.40	71.55	411.57	-
Filing Date Shares Outstanding	3.97	1.96	0.35	0.02	-
Total Common Shares Outstanding	35.3	0.3	0.03	0.02	-
Working Capital	91.99	8.1	1.36	4.13	4.68
Book Value Per Share	2.61	27.15	52.11	269.43	-
Tangible Book Value	91.99	8.1	1.49	4.24	4.63
Tangible Book Value Per Share	2.61	27.15	52.11	269.43	-

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q